Results Show Encouraging Survival Data: Nintedanib for Mesothelioma
On June 5, Anna Nowak, MD, PhD, of the University of Western Australia and member of the Meso Foundation’s Science Advisory Board, presented phase II
MESOTHELIOMA NEWS
Scroll to find news of interest to you, or search by category. The Mesothelioma Applied Research Foundation covers mesothelioma news for patients and their families. Our write-ups are heavily reliant on peer-reviewed medical research studies with input from mesothelioma experts from around the world but are also accessible to non-medical readers.
On June 5, Anna Nowak, MD, PhD, of the University of Western Australia and member of the Meso Foundation’s Science Advisory Board, presented phase II
This morning, Arnaud Scherpereel, MD, PhD, head of the Pulmonary and Thoracic Oncology Department at the University Hospital of Lille in France, presented the results
Getting stepped down to the floor was a very nice change from the ICU. For one thing, I was feeling better. That was the whole
In complete contradistinction to the ambiguity of the long white coat, you, dear patient, are wearing something that tells the entire world precisely who you
A few days passed in the hospital. Some of my friends came to visit. The mix of people who came to visit was interesting, too.
Mesothelioma is best known as the cancer associated with exposure to asbestos. A lesser known fact about mesothelioma is that the period between the exposure/s
by Ann Toney On July 2, 2013, I checked myself into an ER, but not the one I worked in. I wanted to be in
We are deeply saddened by Tara DeAugustinis’ passing. Tara and her husband Rich have become symbols of strength in the mesothelioma community, as they shared their story with the world. Through regular updates beginning with Tara’s diagnosis in early 2016, they informed us of their joys and successes, setbacks and heartbreaks. They taught us that even in the darkest moments life has some light in store. They inspired us with their courage, kindness, honesty and positivity.
Get the latest information about mesothelioma, clinical trials, patient stories, community events, and much more!